Quest Diagnostics Launches Consumer-Facing AI on Its App and Portal
The company’s patients can use AI to look at trends going back five years
The company’s patients can use AI to look at trends going back five years
From – Diagnostic Testing & Emerging Technologies
The U.S. Preventive Services Task Force (USPSTF) added molecular colorectal cancer (CRC) screening to its newly updated guidelines, but stopped short of…
From – Diagnostic Testing & Emerging Technologies
Health care experts predict growth and maturation happening in the field of personalized medicine in the next two…
From – Diagnostic Testing & Emerging Technologies
Routine, nationwide molecular profiling of patients with advanced non-small cell lung cancer (NSCLC) is feasible and the screening detects actionable alterations that…
From – Diagnostic Testing & Emerging Technologies
There is universal recognition that genomic information has forever changed oncology care and is increasingly driving treatment decisions. For patients who have exhausted standard therapy or with…